Strikingly, despite increased sensitivity to MCL1 inhibition, PBRM1 mutant ccRCC cell lines had lower endogenous levels of MCL1 (Supplementary Figure S2A). This evidence concerns the gene MCL1 and nonpapillary renal cell carcinoma.